{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/06/3340531/0/es/Theriva-Biologics-anuncia-que-se-ha-administrado-la-primera-dosis-a-un-paciente-en-el-ensayo-cl%C3%ADnico-VIRAGE2-de-Fase-IIa-destinado-a-evaluar-una-administraci%C3%B3n-m%C3%A1s-frecuente-de-VCN.html", "message": "News view counter 868513 successfully enlarged"}